Chronic Kidney Disease

Among patients hospitalized with COVID-19, dapagliflozin was well tolerated and did not increase risk of AKI in patients, according to data published in the Clinical Journal of the American Society of Nephrology.

Compared with patients on hemodialysis with a disengaged mindset, those with an engaged mindset exhibited more adaptive coping skills, moved more and had a normal body weight habitus, according to data published in Kidney Medicine.

Compared with healthy controls, patients with chronic kidney disease or on hemodialysis have lower serum zinc levels more frequently than reported in daily clinical practice, according to data published in the Journal of Renal Nutrition.

The expanded indication for BP-lowering treatment by the 2021 Kidney Disease: Improving Global Outcomes guideline affects more than 10% of patients with chronic kidney disease, who are at higher CVD risk than those with well-controlled BP.

BOSTON — In this video from the National Kidney Foundation Spring Clinical Meetings, Joseph A. Vassalotti, MD, reviews results from late-breaking clinical trials.

Fresenius Medical Care North America announced the FDA has awarded 510(k) clearance to its VersiPD cycler.

BOSTON — Intubated patients with COVID-19 pneumonia who develop AKI in the hospital are at risk for developing chronic kidney disease, according to a presenter at the National Kidney Foundation Spring Clinical Meetings.

BOSTON — In this video from the National Kidney Foundation Spring Clinical Meetings, Bob Nagy, vice-president of sales for AvoMD, discusses how its clinical decision support platform is making guidelines available at point-of-care.

The FDA has accepted a new drug application for daprodustat, which was filed by GlaxoSmithKline plc, according to a press release.

Strive Health and Evolent Care Partners have entered into a new partnership to support 211 primary care providers in Michigan and North Carolina who participate in the Evolent Care Partners’ ACO.